San Francisco – June 23, 2016 – Cooley advised the underwriters on Dermira's follow-on offering of 5,175,000 shares of common stock for gross proceeds of $144.9 million. Dermira, which is traded on The NASDAQ Global Select Market, is a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of patients with dermatologic diseases.
Leerink Partners, Cowen and Company and Guggenheim Securities acted as joint book-running managers for the offering and Needham & Company acted as co-manager for the offering.
Cooley advised the underwriters on Dermira's IPO in October 2014 and its subsequent follow-on in August 2015.
The Cooley corporate and securities team advising the underwriters on this follow-on included Drew Williamson, Charlie Kim, Dave Peinsipp, Kristin VanderPas, Eric Cheng, Denny Won and Phillip McGill.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.